Takeda Pharmaceutical Co (JP:4502) has released an update.
Takeda Pharmaceutical has finalized the issuance of new shares and the disposal of treasury shares as part of its Long-Term Incentive Plan for non-Japanese employees, with slight adjustments from the original plan due to some allotees forfeiting their rights. The total shares involved after the adjustment are 15,846,346, valued at 67.2 billion yen, which is expected to have a negligible effect on the company’s financial outlook for the fiscal year ending March 2025. Takeda focuses on life-transforming treatments across various therapeutic and business areas and operates globally with a workforce in around 80 countries.
For further insights into JP:4502 stock, check out TipRanks’ Stock Analysis page.
